REMS Program Companies, a group that manufactures extended-release and long-acting opioids, awarded the grant.
The grant incorporates elements of the recently approved FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics guideline program. The initiative will be launched on June 15, through a certified, online curriculum.
More Articles on Pain Management:
Advanced Pain Management, Beaver Dam Community Hospitals Partner to Open Clinic
Indiana Senate Passes Pain Clinic Regulating Bill
American Academy of Pain Medicine: Opioid Medication Label Change Won’t Solve Prescription Drug Abuse
